4.2 Article

Spectrum of MLL2 (ALR) Mutations in 110 Cases of Kabuki Syndrome

Journal

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 155A, Issue 7, Pages 1511-1516

Publisher

WILEY-BLACKWELL
DOI: 10.1002/ajmg.a.34074

Keywords

Kabuki syndrome; MLL2; ALR; Trithorax group histone methyltransferase

Funding

  1. National Institutes of Health/National Heart Lung and Blood Institute [5R01HL094976]
  2. National Institutes of Health/National Human Genome Research Institute [5R21HG004749, 1RC2HG005608, 5RO1HG004316, T32HG00035]
  3. National Institute of Heath/National Institute of Environmental Health Sciences [HHSN273200800010C]
  4. National Institute of Neurological Disorders and Stroke [RO1NS35102]
  5. NIHR Manchester Biomedical Research Centre
  6. Ministry of Health, Labour and Welfare of Japan
  7. Japan Science and Technology Agency
  8. Society for the Promotion of Science
  9. Life Sciences Discovery Fund [2065508, 0905001]
  10. Washington Research Foundation
  11. National Institutes of Health/National Institute of Child Health and Human Development [1R01HD048895, 5K23HD057331]
  12. Ministry of Health, Labour and Welfare
  13. Agency for Science, Technology and Research, Singapore
  14. Grants-in-Aid for Scientific Research [23590383, 21390100, 23689052, 22659071, 23591506] Funding Source: KAKEN

Ask authors/readers for more resources

Kabuki syndrome is a rare, multiple malformation disorder characterized by a distinctive facial appearance, cardiac anomalies, skeletal abnormalities, and mild to moderate intellectual disability. Simplex cases make up the vast majority of the reported cases with Kabuki syndrome, but parent-to-child transmission in more than a half-dozen instances indicates that it is an autosomal dominant disorder. We recently reported that Kabuki syndrome is caused by mutations in MLL2, a gene that encodes a Trithorax-group histone methyltransferase, a protein important in the epigenetic control of active chromatin states. Here, we report on the screening of 110 families with Kabuki syndrome. MLL2 mutations were found in 81/110 (74%) of families. In simplex cases for which DNA was available from both parents, 25 mutations were confirmed to be de novo, while a transmitted MLL2 mutation was found in two of three familial cases. The majority of variants found to cause Kabuki syndrome were novel nonsense or frameshift mutations that are predicted to result in haploinsufficiency. The clinical characteristics of MLL2 mutation-positive cases did not differ significantly from MLL2 mutation-negative cases with the exception that renal anomalies were more common in MLL2 mutation-positive cases. These results are important for understanding the phenotypic consequences of MLL2 mutations for individuals and their families as well as for providing a basis for the identification of additional genes for Kabuki syndrome. (C) 2011 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available